Drew M Pardoll (Drew Pardoll)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 46

Top Topics

Liver Metastases

Papillary Thyroid

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Ayush Pant, Aanchal Jain, Yiyun Chen, Kisha K Patel, Laura Saleh, Stephany Y Tzeng, Ryan T Nitta, Liang Zhao, Caren Yu-Ju Wu, Maria Bederson, William Lee Wang, Brandon Hwa-Lin Bergsneider, John Choi, Ravi Medikonda, Rohit Verma, Kwang Bog Cho, Lily H Kim, Jennifer E Kim, Eli Yazigi, Si Yeon Lee, Sakthi Rajendran, Prajwal Rajappa, Crystal L Mackall, Gordon Li, Betty M Tyler, Henry Brem, Drew M Pardoll, Michael Lim, Christopher M Jackson
The CCR6-CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors. Cancer immunology research (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Monali Praharaj, Fan Shen, Alex J Lee, Liang Zhao, Thomas R Nirschl, Debebe Theodros, Alok K Singh, Xiaoxu Wang, Kenneth M Adusei, Kara A Lombardo, Raekwon A Williams, Laura A Sena, Elizabeth A Thompson, Ada J Tam, Srinivasan Yegnasubramanian, Edward J Pearce, Robert D Leone, Jesse Alt, Rana Rais, Barbara S Slusher, Drew M Pardoll, Jonathan D Powell, Jelani C Zarif
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers. Cancer immunology research 12 (7) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature (2024)
Monali Praharaj, Fan Shen, Alex J Lee, Liang Zhao, Thomas R Nirschl, Debebe Theodros, Alok K Singh, Xiaoxu Wang, Kenneth M Adusei, Kara A Lombardo, Raekwon A Williams, Laura A Sena, Elizabeth A Thompson, Ada J Tam, Srinivasan Yegnasubramanian, Edward J Pearce, Robert D Leone, Jesse Alt, Rana Rais, Barbara S Slusher, Drew M Pardoll, Jonathan D Powell, Jelani C Zarif
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers. Cancer immunology research 12 (7) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Brian J Mog, Nikita Marcou, Sarah R DiNapoli, Alexander H Pearlman, Tushar D Nichakawade, Michael S Hwang, Jacqueline Douglass, Emily Han-Chung Hsiue, Stephanie A Glavaris, Katharine M Wright, Maximilian Ferdinand Konig, Suman Paul, Nicolas Wyhs, Jiaxin Ge, Michelle S Miller, P Aitana Azurmendi, Evangeline Watson, Drew M Pardoll, Sandra B Gabelli, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities. Science translational medicine 16 (755) (2024)
Monali Praharaj, Fan Shen, Alex J Lee, Liang Zhao, Thomas R Nirschl, Debebe Theodros, Alok K Singh, Xiaoxu Wang, Kenneth M Adusei, Kara A Lombardo, Raekwon A Williams, Laura A Sena, Elizabeth A Thompson, Ada J Tam, Srinivasan Yegnasubramanian, Edward J Pearce, Robert D Leone, Jesse Alt, Rana Rais, Barbara S Slusher, Drew M Pardoll, Jonathan D Powell, Jelani C Zarif
Metabolic reprogramming of tumor-associated macrophages using glutamine antagonist JHU083 drives tumor immunity in myeloid-rich prostate and bladder cancer tumors. Cancer immunology research (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature (2024)
Monali Praharaj, Fan Shen, Alex J Lee, Liang Zhao, Thomas R Nirschl, Debebe Theodros, Alok K Singh, Xiaoxu Wang, Kenneth M Adusei, Kara A Lombardo, Raekwon A Williams, Laura A Sena, Elizabeth A Thompson, Ada J Tam, Srinivasan Yegnasubramanian, Edward J Pearce, Robert D Leone, Jesse Alt, Rana Rais, Barbara S Slusher, Drew M Pardoll, Jonathan D Powell, Jelani C Zarif
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers. Cancer immunology research 12 (7) (2024)
Tushar D Nichakawade, Jiaxin Ge, Brian J Mog, Bum Seok Lee, Alexander H Pearlman, Michael S Hwang, Sarah R DiNapoli, Nicolas Wyhs, Nikita Marcou, Stephanie Glavaris, Maximilian Ferdinand Konig, Sandra B Gabelli, Evangeline Watson, Cole Sterling, Nina Wagner-Johnston, Sima Rozati, Lode Swinnen, Ephraim Fuchs, Drew M Pardoll, Kathy Gabrielson, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Surojit Sur, Bert Vogelstein, Suman Paul
TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature 628 (8007) (2024)
Ronan J Kelly, Blair V Landon, Blair A Jobe, Dipika Singh, Jenna V Canzoniero, Archana Balan, Russell K Hales, K Ranh Voong, Richard J Battafarano, Blair A Jobe, Stephen C Yang, Stephen Broderick, Jinny Ha, Kristen A Marrone, Gavin Pereira, Nisha Rao, Aryan Borole, Katerina Karaindrou, Zineb Belcaid, James R White, Suqi Ke, Ali I Amjad, Benny Weksler, Eun Ji Shin, Elizabeth Thompson, Kellie N Smit, Drew M Pardoll, Chen Hu, Josephine L Feliciano, Valsamo Anagnostou, Vincent K Lam
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses. Nature medicine 30 (4) (2024)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Samuel Rosner, Joshua E Reuss, Marianna L Zahurak, Jiajia Zhang, Zhen Zeng, Janis M Taube, Valsamo Anagnostou, Kellie N Smit, Joanne Riemer, Peter B Illei, Stephen R Broderick, David R Jones, Suzanne L Topalian, Drew M Pardoll, Julie R Brahmer, Jamie E Chaft, Patrick M Forde
Five-Year Clinical Outcomes after Neoadjuvant Nivolumab in Resectable Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Arbor G Dykema, Jiajia Zhang, Laurene S Cheung, Sydney Connor, Boyang Zhang, Zhen Zeng, Christopher M Cherry, Taibo Li, Justina X Caushi, Marni Nishimoto, Andrew J Munoz, Zhicheng Ji, Wenpin Hou, Wentao Zhan, Dipika Singh, Tianbei Zhang, Rufiaat Rashid, Marisa Mitchell-Flack, Sadhana Bom, Ada Tam, Nick Ionta, Thet H K Aye, Yi Wang, Camille A Sawosik, Lauren E Tirado, Luke M Tomasovic, Derek VanDyke, Jamie B Spangler, Valsamo Anagnostou, Stephen Yang, Jonathan D Spicer, Roni Rayes, Janis M Taube, Julie R Brahmer, Patrick M Forde, Srinivasan Yegnasubramanian, Hongkai Ji, Drew M Pardoll, Kellie N Smit
Lung tumor-infiltrating T reg have divergent transcriptional profiles and function linked to checkpoint blockade response. Science immunology 8 (87) (2023)
Sara E Schad, Andrew Chow, Levi Mark Mangarin, Heng Pan, Jiajia Zhang, Nicholas Ceglia, Justina X Caushi, Nicole Malandro, Roberta Zappasodi, Mathieu Gigoux, Daniel Hirschhorn, Sadna Budhu, Masataka Amisaki, Monica B Arniella, David Redmond, Jamie E Chaft, Patrick M Forde, Justin F Gainor, Matthew D Hellmann, Vinod P Balachandran, Sohrab P Shah, Kellie N Smit, Drew M Pardoll, Olivier Elemento, Jedd D Wolchok, Taha Merghoub
Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions. The Journal of experimental medicine 219 (6) (2022)
John-William Sidhom, Giacomo Oliveira, Petra Ross-MacDonald, Megan Wind-Rotolo, Catherine J Wu, Drew M Pardoll, Alexander S Baras
Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy. Science advances 8 (37) (2022)
Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog, Michael S Hwang, Sarah R DiNapoli, Alexander H Pearlman, Michelle S Miller, Katharine M Wright, P Aitana Azurmendi, Qing Wang, Suman Paul, Annika Schaefer, Andrew D Skora, Marco Dal Molin, Maximilian Ferdinand Konig, Qiang Liu, Evangeline Watson, Yana Li, Michael B Murphy, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Sandra B Gabelli, Kenneth W Kinzler, Bert Vogelstein, Shibin Zhou
Bispecific antibodies targeting mutant RAS neoantigens. Science immunology 6 (57) (2022)
Rajendra Kumar, Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen, Max Coffey, Deven Topiwala, Carolina Gomes, Busra Ozbek, Tracy Jones, Marc Rosen, Liang Dong, Sadie Wiens, W Nathaniel Brennen, John T Isaacs, Angelo M DeMarzo, Mark C Markowski, Emmanuel S Antonarakis, David Z Qian, Kenneth J Pienta, Drew M Pardoll, Michael A Carducci, Samuel R Denmeade, Sushant K Kachhap
Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer. Cancer research 81 (23) (2021)
Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass, Michael S Hwang, Brian J Mog, Alexander H Pearlman, Suman Paul, Sarah R DiNapoli, Maximilian Ferdinand Konig, Qing Wang, Annika Schaefer, Michelle S Miller, Andrew D Skora, P Aitana Azurmendi, Michael B Murphy, Qiang Liu, Evangeline Watson, Yana Li, Drew M Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, Sandra B Gabelli, Shibin Zhou
Targeting a neoantigen derived from a common TP53 mutation. Science (New York, N.Y.) 371 (6533) (2021)
Zoya Alteber, Maya F Kotturi, Sarah Whelan, Sudipto Ganguly, Emmanuel Weyl, Drew M Pardoll, John Hunter, Eran Ophir
Therapeutic Targeting of Checkpoint Receptors within the DNAM1 Axis. Cancer discovery 11 (5) (2021)
Liam Chung, David R Maestas, Andriana Lebid, Ashlie Mageau, Gedge D Rosson, Xinqun Wu, Matthew T Wolf, Ada J Tam, Isabel Vanderzee, Xiaokun Wang, James I Andorko, Hong Zhang, Radhika Narain, Kaitlyn Sadtler, Hongni Fan, Daniela Cˇiháková, Claude Jourdan Le Saux, Franck Housseau, Drew M Pardoll, Jennifer H Elisseeff
Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans. Science translational medicine 12 (539) (2021)
Suman Paul, Alexander H Pearlman, Jacqueline Douglass, Brian J Mog, Emily Han-Chung Hsiue, Michael S Hwang, Sarah R DiNapoli, Maximilian Ferdinand Konig, Patrick A Brown, Katharine M Wright, Surojit Sur, Sandra B Gabelli, Yana Li, Gabriel Ghiaur, Drew M Pardoll, Nickolas Papadopoulos, Chetan Bettegowda, Kenneth W Kinzler, Shibin Zhou, Bert Vogelstein
TCR β chain-directed bispecific antibodies for the treatment of T cell cancers. Science translational medicine 13 (584) (2021)
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, Tricia R Cottrell, Julie E Stein, Elizabeth L Engle, Haiying Xu, Aleksandra Ogurtsova, Charles Roberts, Daphne Wang, Peter Nguyen, Qingfeng Zhu, Sigfredo Soto-Diaz, Jose Loyola, Inbal B Sander, Pok Fai Wong, Shlomit Jessel, Joshua Doyle, Danielle Signer, Richard Wilton, Jeffrey S Roskes, Margaret Eminizer, Seyoun Park, Joel C Sunshine, Elizabeth D Thompson, Alexander S Baras, Angelo M DeMarzo, Suzanne L Topalian, Harriet Kluger, Leslie Cope, Evan J Lipson, Ludmila V Danilova, Robert A Anders, David L Rimm, Drew M Pardoll, Alexander S Szalay, Janis M Taube
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade. Science (New York, N.Y.) 372 (6547) (2021)
Fyza Y Shaikh, James R White, Joell J Gills, Taiki Hakozaki, Corentin Richard, Bertrand Routy, Yusuke Okuma, Mykhaylo Usyk, Abhishek Pandey, Jeffrey S Weber, Jiyoung Ahn, Evan J Lipson, Jarushka Naidoo, Drew M Pardoll, Cynthia L Sears
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Suzanne L Topalian, Janis M Taube, Drew M Pardoll
Neoadjuvant checkpoint blockade for cancer immunotherapy. Science (New York, N.Y.) 367 (6477) (2020)
Elana Ben-Akiva, Randall A Meyer, Hongzhe Yu, Jonathan T Smith, Drew M Pardoll, Jordan J Green
Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal. Science advances 6 (16) (2020)
Evan J Lipson, Fizza F Naqvi, Manisha J Loss, Megan D Schollenberger, Drew M Pardoll, Jack Moore, Daniel C Brennan
Kidney retransplantation after anti-programmed cell death-1 (PD-1)-related allograft rejection. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20 (8) (2020)
Lingling Chen, Teniola Oke, Nicholas Siegel, Gady Cojocaru, Ada J Tam, Richard L Blosser, Jessica Swailes, John A Ligon, Andriana Lebid, Carol D Morris, Adam S Levin, Daniel S Rhee, Fabian M Johnston, Jonathan B Greer, Christian F Meyer, Brian H Ladle, Elizabeth D Thompson, Elizabeth A Montgomery, Woonyoung Choi, David J McConkey, Robert A Anders, Drew M Pardoll, Nicolas J Llosa
The Immunosuppressive Niche of Soft-Tissue Sarcomas is Sustained by Tumor-Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)